Japan Newborn Screening Market Size & Outlook, 2023-2030
Japan newborn screening market, 2018-2030 (US$M)
Related Markets
Japan newborn screening market highlights
- The Japan newborn screening market generated a revenue of USD 56.6 million in 2023 and is expected to reach USD 92.5 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.3% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
Newborn screening market data book summary
| Market revenue in 2023 | USD 56.6 million |
| Market revenue in 2030 | USD 92.5 million |
| Growth rate | 7.3% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, Japan accounted for 7.1% of the global newborn screening market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Thailand newborn screening market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 75.5 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.56% in 2023. Horizon Databook has segmented the Japan newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Being a developed economy, Japan is expected to provide huge platform for growth of newborn screening market over the forecast period. Japan started with the phenylketonuria (PKU) screening and only six conditions were screened in newborns till late 1990s.
The rising awareness levels and high disposable incomes are the factors boosting the market growth. Availability of advanced technology and ability to develop new devices by most of the companies in the country are the factors expected to continue the high growth rate of the market in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan newborn screening market size, by technology, 2018-2030 (US$M)
Japan Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
